PatientsVille.com Logo

PatientsVille

Asunra Side Effects

Common Asunra Side Effects


The most commonly reported Asunra side effects (click to view or check a box to report):

Death (23)
Pyrexia (6)
Iron Overload (5)
Diarrhoea (4)
Myocardial Infarction (3)
Haematological Malignancy (3)
Blood Creatinine Increased (3)
Albumin Urine Present (3)
Hypertensive Nephropathy (3)
Oedema Peripheral (3)
Somnolence (3)
Swelling Face (3)
Pyuria (3)
Haematemesis (2)
Disease Progression (2)
Post Procedural Complication (2)
Multi-organ Failure (2)
Heart Rate Increased (2)
Pain (2)
Paralysis (2)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Asunra Side Effects Reported to FDA

The following Asunra reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Asunra on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
Pain, Movement Disorder, Hypophagia, Gastrointestinal Disorder
This is a report of a 40-year-old female patient (weight: NA) from BD, suffering from the following symptoms/conditions: thalassaemia, who was treated with Asunra (dosage: 600 Mg, Daily, start time: Aug 20, 2013), combined with: NA. and developed a serious reaction and side effect(s). The consumer presented with:
  • Pain
  • Movement Disorder
  • Hypophagia
  • Gastrointestinal Disorder
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Asunra treatment in female patients, resulting in pain side effect.

Pain, Syncope, Dyspnoea
This report suggests a potential Asunra Pain, Syncope, Dyspnoea side effect(s) that can have serious consequences. A 55-year-old female patient (weight: NA) from IN was diagnosed with the following symptoms/conditions: iron overload and used Asunra (dosage: 400 Mg, Qd) starting Jun 11, 2012. Soon after starting Asunra the patient began experiencing various side effects, including:
  • Pain
  • Syncope
  • Dyspnoea
Drugs used concurrently: NA.The patient was hospitalized. Although Asunra demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as death, may still occur.


This problem was reported by a physician from PK. A 14-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: thalassaemia. On NS this consumer started treatment with Asunra (dosage: 800 Mg, Qd). The following drugs were being taken at the same time: NA. When commencing Asunra, the patient experienced the following unwanted symptoms/side effects:
    Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as death, may become evident only after a product is in use by the general population.

    Infection, Heart Rate Increased, Pyrexia
    This is a report of a 8-year-old female patient (weight: NA) from COUNTRY NOT SPECIFIED. The patient developed the following symptoms/conditions: thalassaemia and was treated with Asunra (dosage: 100 Mg, Daily) starting NS. Concurrently used drugs: NA.Soon after that, the consumer experienced the following side effects:
    • Infection
    • Heart Rate Increased
    • Pyrexia
    This opens a possibility that Asunra treatment could cause the above reactions, including infection, and some female subjects may be more susceptible.


    Anal Erosion, Anal Fissure, Haemorrhoids, Painful Defaecation, Diarrhoea
    A 49-year-old male patient (weight: NA) from IN with the following symptoms/conditions: myelofibrosis started Asunra treatment (dosage: 800 Mg, Per Day) on NS. Soon after starting Asunra treatment, the subject experienced various side effects, including:
    • Anal Erosion
    • Anal Fissure
    • Haemorrhoids
    • Painful Defaecation
    • Diarrhoea
    Concurrently used drugs: NA. This finding indicates that some male patients could be more vulnerable to Asunra.


    A 33-year-old male patient from IN (weight: NA) experienced symptoms, such as: thalassaemia and was treated with Asunra(dosage: 400 Mg X 3). The treatment was initiated on Jun 02, 2012. After that a consumer reported the following side effect(s):
      Concurrently used drugs, which potentially could have contributed to side effect(s) or affected Asunra efficacy: NA.

      Dengue Fever
      In this report, Asunra was administered for the following condition: thalassaemia.A 65-year-old male consumer from IN (weight: NA) started Asunra treatment (dosage: 1600 Mg, Qd) on Jan 24, 2012.Sometime after starting the treatment, the patient complained of the following side effect(s):
      • Dengue Fever
      A possible interaction with other drugs could have contributed to this reaction: NA.The patient was hospitalized.Establishing a causal relationship between a specific drug and consumer's side effects is complex, but it is possible that in this report Asunra treatment could be related to the listed above side effect(s).


      This is a report of the following Asunra side effect(s):
        A 24-year-old female patient from BANGLADESH (weight: NA) presented with the following condition: thalassaemia and received a treatment with Asunra (dosage: Unk Ukn, Unk) starting: NS.The following concurrently used drugs could have generated interactions: NA.This report suggests that a Asunra treatment could be associated with the listed above side effect(s).

        Paralysis, Cardiac Disorder
        This Asunra report was submitted by a 12-year-old female consumer from INDIA (weight: NA). The patient was diagnosed with: iron overload and Asunra was administered (dosage: 400 Mg) starting: Jan 01, 2009. The consumer developed a set of symptoms:
        • Paralysis
        • Cardiac Disorder
        Other drugs used simultaneously: NA.The patient was hospitalized.Those unexpected symptoms could be linked to a Asunra treatment, however establishing a potential drug-safety problem requires a more detailed clinical analysis.


        This is a report of a possible correlation between Asunra use and the following symptoms/side effect(s):
          which could contribute to an assessment of Asunra risk profile.A 4-year-old female consumer from INDIA (weight: NA) was suffering from NA and was treated with Asunra (dosage: 300mg (3 Tablets Of 100mg).) starting NS.Other concurrent medications: NA.

          Cerebral Haemorrhage
          A 19-year-old male patient from INDIA (weight: NA) presented with the following symptoms: NA and after a treatment with Asunra (dosage: 400 Mg, Unk) experienced the following side effect(s):
          • Cerebral Haemorrhage
          The treatment was started on NS. Asunra was used in combination with the following drugs: NA.This report could alert potential Asunra consumers.

          Transplant Failure, Haemoglobin Decreased, Platelet Count Decreased
          In this report, a 75-year-old female patient from INDIA (weight: NA) was affected by a possible Asunra side effect.The patient was diagnosed with NA. After a treatment with Asunra (dosage: 400 Mg, Daily, start date: NS), the patient experienced the following side effect(s):
          • Transplant Failure
          • Haemoglobin Decreased
          • Platelet Count Decreased
          The following simultaneously used drugs could have led to this reaction: NA.The findings here stress that side effects should be taken into consideration when evaluating a Asunra treatment.

          Lung Infection
          This is a report of a 14-year-old male patient from INDIA (weight: NA), who used Asunra (dosage: 400 Mg) for a treatment of NA. After starting a treatment on NS, the patient experienced the following side effect(s):
          • Lung Infection
          The following drugs could possibly have interacted with the Asunra treatment NA.Taken together, these observations suggest that a Asunra treatment could be related to side effect(s), such as Lung Infection.


          This death side effect was reported by a consumer or non-health professional from INDIA. A 25-year-old male patient (weight:NA) experienced the following symptoms/conditions: NA. The patient was prescribed Asunra (dosage: 100 Mg, Unk), which was started on NS. Concurrently used drugs: NA. When starting to take Asunra the consumer reported the following symptoms:
            These side effects may potentially be related to Asunra.

            Chest Pain, Haematemesis
            This is a Asunra side effect report of a 22-year-old male patient (weight:NA) from INDIA, suffering from the following symptoms/conditions: NA, who was treated with Asunra (dosage:400 Mg, Unk, start time: NS), combined with: NA., and developed a serious reaction and a chest pain side effect. The patient presented with:
            • Chest Pain
            • Haematemesis
            which developed after the beginning of treatment. This side effect report can indicate a possible existence of increased vulnerability to Asunra treatment in male patients suffering from NA, resulting in chest pain.

            Haematemesis, Paralysis
            This report suggests a potential Asunra haematemesis side effect(s) that can have serious consequences. A 13-year-old female patient from INDIA (weight:NA) was diagnosed with the following health condition(s): NA and used Asunra (dosage: NA) starting NS. Soon after starting Asunra the patient began experiencing various side effects, including:
            • Haematemesis
            • Paralysis
            Drugs used concurrently:NA. Although Asunra demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as haematemesis, may still occur.

            Pyuria, Hypertensive Nephropathy, Swelling Face, Oedema Peripheral, Blood Creatinine Increased, Albumin Urine Present
            This pyuria problem was reported by a physician from INDIA. A 19-year-old female patient (weight: NA) was diagnosed with the following medical condition(s): iron overload,thalassaemia beta.On Sep 09, 2008 a consumer started treatment with Asunra (dosage: 25 Mg/kg/day). The following drugs/medications were being taken at the same time: NA. When commencing Asunra, the patient experienced the following unwanted symptoms /side effects:
            • Pyuria
            • Hypertensive Nephropathy
            • Swelling Face
            • Oedema Peripheral
            • Blood Creatinine Increased
            • Albumin Urine Present
            Although all drugs are carefully tested before they are licensed for use, they carry potential side effect risks. Some side effects, such as pyuria, may become evident only after a product is in use by the general population.


            This is a Asunra side effect report of a 75-year-old female patient (weight: NA) from INDIA. The patient developed the following symptoms/conditions: NA and was treated with Asunra (dosage: 400 Mg, Unk) starting NS. Concurrently used drugs: NA. Soon after that, the consumer experienced the following of symptoms:
              This opens a possibility that Asunra could cause death and that some female patients may be more susceptible.

              Albumin Urine Present, Blood Creatinine Increased, Hypertensive Nephropathy, Oedema Peripheral, Pyuria, Swelling Face
              A 19-year-old female patient (weight: NA) from INDIA with the following symptoms: thalassaemia beta,iron overload started Asunra treatment (dosage: 1200 Mg, Unk) on Sep 09, 2008. Soon after starting Asunra treatment, the consumer experienced several side effects, including:
              • Albumin Urine Present
              • Blood Creatinine Increased
              • Hypertensive Nephropathy
              • Oedema Peripheral
              • Pyuria
              • Swelling Face
              . Concurrently used drugs: NA. This finding indicates that some patients can be more vulnerable to developing Asunra side effects, such as albumin urine present.

              Hepatic Infection
              This hepatic infection side effect was reported by a consumer or non-health professional from INDIA. A 73-year-old male patient (weight:NA) experienced the following symptoms/conditions: NA.The patient was prescribed Asunra (dosage: 400 Mg, Unk), which was started on NS. Concurrently used drugs: NA..When starting to take Asunra the consumer reported symptoms, such as:
              • Hepatic Infection
              These side effects may potentially be related to Asunra.


              This is a report of a 8-year-old female patient (weight: NA) from INDIA, suffering from the following symptoms/conditions: NA, who was treated with Asunra (dosage: 1 Tablet Of 400 Mg And 1 Tablet Of 100 Mg), start time: May 01, 2010), combined with: NA. and developed a serious reaction and side effect(s). The consumer presented with:
                which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Asunra treatment in female patients, resulting in death side effect.

                Myelodysplastic Syndrome
                This report suggests a potential Asunra Myelodysplastic Syndrome side effect(s) that can have serious consequences. A 53-year-old female patient (weight: NA) from INDIA was diagnosed with the following symptoms/conditions: NA and used Asunra (dosage: 400 Mg, 2 Tablets) starting NS. Soon after starting Asunra the patient began experiencing various side effects, including:
                • Myelodysplastic Syndrome
                Drugs used concurrently: NA. Although Asunra demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as myelodysplastic syndrome, may still occur.


                This problem was reported by a consumer or non-health professional from INDIA. A 15-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On NS this consumer started treatment with Asunra (dosage: 2 Tab Of 400mg). The following drugs were being taken at the same time: NA. When commencing Asunra, the patient experienced the following unwanted symptoms/side effects:
                  Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as death, may become evident only after a product is in use by the general population.

                  Cerebral Haemorrhage, Diarrhoea, Haematological Malignancy, Pyrexia
                  This is a report of a 58-year-old male patient (weight: NA) from INDIA. The patient developed the following symptoms/conditions: NA and was treated with Asunra (dosage: 400 Mg, Bid) starting NS. Concurrently used drugs: NA.Soon after that, the consumer experienced the following side effects:
                  • Cerebral Haemorrhage
                  • Diarrhoea
                  • Haematological Malignancy
                  • Pyrexia
                  The patient was hospitalized. This opens a possibility that Asunra treatment could cause the above reactions, including cerebral haemorrhage, and some male subjects may be more susceptible.

                  Pharyngitis
                  A 11-year-old male patient (weight: NA) from INDIA with the following symptoms/conditions: NA started Asunra treatment (dosage: 400 Mg, One Tablet) on NS. Soon after starting Asunra treatment, the subject experienced various side effects, including:
                  • Pharyngitis
                  Concurrently used drugs: NA. This finding indicates that some male patients could be more vulnerable to Asunra.

                  1 of 3 



                  Keep Track of Side Effects

                  Note Your Observations

                  It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

                  Why Your Notes are Important

                  Your notes could be helpful in several ways:

                • You can use them to remind you of details that may alert your health care professional(s) to a problem
                • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

                • Log Form

                  You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

                  Medicine Name and Dosage:
                  Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
                  Scale: 1 = very mild to 10 = very bad

                  You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


                  Discuss Asunra Side Effects

                  Did You Have a Asunra Side Effect?

                  Yes, Severe
                  Yes, Moderate
                  Yes, Minor
                  No

                  How Effective is Asunra for You?

                  Exceeded Expectations
                  Effective
                  Somewhat Effective
                  Not Effective

                  Asunra Safety Alerts, Active Ingredients, Usage Information

                  More About Asunra

                  Side Effects reported to FDA: 66

                  Asunra safety alerts: No

                  Reported deaths: 63

                  Reported hospitalizations: 10

                  Latest Asunra clinical trials